PANCREATIC CANCER ACTION NETWORK, INC.
MANHATTAN BEACH, CA

Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc. Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical trial. The Pancreatic Cancer Action Network strongly recommends clinical trials at diagnosis and during every treatment decision. In the fight against pancreatic cancer, clinical trials often provide the best treatment options, and they give patients early access to cutting-edge treatments that can lead to progress in research, improved treatment options and better outcomes. Our Associates can run a search for you and provide a personalized list of clinical trials that match what you need. They will base the search on information you provide, such as how far you’re willing to travel, your diagnosis, and your treatment history. Our Patient Central Associates are available to talk through your personalized clinical trials information. They can provide in-depth details and answer any questions you may have. Then, discuss search results with your healthcare team to determine if a clinical trial is the right option for you. See why the Pancreatic Cancer Action Network strongly recommends clinical trials at diagnosis and during every treatment decision. Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc. About the Pancreatic Cancer Action Network Founded in 1999, the Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer . In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to Why We Are Relentless Trailblazers We have a proven track record of taking on incredible challenges and meeting our goals. We shape policy, mold opinion and firm up funding. We don’t take no for an answer. Hope doesn’t always mean action, but action is our middle name. We are the only organization with a nationwide grassroots army, inspiring over one million people to take action to end pancreatic cancer. We serve the community as the one organization that attacks the disease through four key areas: In 2011, our organization declared a bold and aggressive vision: After seeing too little progress in pancreatic cancer survival in over half a century, the Pancreatic Cancer Action Network put a stake in the ground to double pancreatic cancer survival by 2020. Today we are aiming to raise $200 million by 2020, which will ensure that we continue to accelerate progress. Increased funding for patient services will help improve the lives of people battling pancreatic cancer today, as well as those who are diagnosed in the future. More patients will know their options, and possibly have the opportunity to enroll in clinical trials that best match their needs. , our personalized medicine service, which provides eligible pancreatic cancer patients and their oncologists with information about the biology of their tumor. Further, information that is gathered through this service can help shape future clinical trials that drive progress for patients. As a result of all of this activity, even greater attention will be focused on the disease across the country and around the world, and more people will have the opportunity to Wage Hope and help rewrite the future of pancreatic cancer. We have identified five key challenges on the road to 2020, but we have a carefully considered plan of attack. Raising $200 million by 2020 will help ensure that we meet these challenges head on. The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020. We are the Pancreatic Cancer Action Network, one of the most highly respected organizations in the nonprofit sector. We’re rewriting the book on how to fight a deadly disease with cutting-edge research that accelerates progress by: bolstering our advocacy efforts on Capitol Hill, supporting our passionate volunteer network, raising national awareness, and providing information, resources and hope to patients and their families. We are an Equal Opportunity Employer valuing diversity! The Pancreatic Cancer Action Network is a nonprofit, 501(c)(3) nationwide network of people dedicated to fighting the world’s toughest cancer. Founded by a group of pancreatic cancer survivors and caregivers in 1999, the organization relentlessly pursues its mission by implementing an aggressive and comprehensive strategy of research, patient support, advocacy and awareness. The Pancreatic Cancer Action Network is headquartered in Manhattan Beach, Calif., and also staffs a Washington, D.C and New York City office. Julie Fleshman became the organization’s first full-time staff person and its first Executive Director in April 2000. Having lost her father to pancreatic cancer in 1999, she has made it her passion and commitment to change the course of the disease. In July 2004, the Board of Directors appointed Fleshman President and CEO. Under her leadership, the Pancreatic Cancer Action Network has grown from a staff of one with revenues of $228,000 to a staff of over 140 with a budget of more than $38 million. Fleshman has spearheaded the charge to ensure the Pancreatic Cancer Action Network achieves its goal to double pancreatic cancer survival by 2020. Her leadership has driven consistent excellence and innovation throughout the programs and services of the organization, including introducing precision medicine service Know Your Tumor